Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

Presenter: Gill Buchanan

REGISTER for free or LOG IN to view this content

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents:  The FINE Registry

We Recommend